Frazier Life Sciences IX, L.P. 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-20 5:17 pm Sale | 2025-08-18 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 3,735,220 7.600% | -2,491,172 (-40.01%) | Filing |
| 2023-09-05 3:11 pm Purchase | 2023-08-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 6,226,392 13.400% | 1,815,285 (+41.15%) | Filing |
| 2023-04-14 12:45 pm Purchase | 2023-04-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 4,411,107 11.600% | 549,326 (+14.22%) | Filing |
| 2022-08-16 12:20 pm Purchase | 2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 3,861,781 10.500% | 294,869 (+8.27%) | Filing |
| 2020-12-18 12:40 pm Unchanged | 2020-12-17 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 3,566,912 12.200% | 0 (Unchanged) | Filing |